We are very pleased to announce that Dr Ana Slipicevic has been appointed as acting CEO of one-carbon therapeutics AB. Ana is joining us from Oncopeptides AB where she has been translational research director and leading a team developing and implementing translational research strategies in the early and late-stage clinical trial pipeline. Dr Ana Slipicevic has previously been leading a research team at Oslo University working on DDR strategies to target cancer.
She will be a great asset to the company!
Dr Eva Ehrnrooth, MD PhD to join One-carbon Therapeutics AB management team as interim CMO
Dr Eva Ehrnrooth (MD PhD) brings + 20 years of
